Skip to main content
Equibles
ENDV logo

ENDV · Endonovo Therapeutics, Inc. · Documents

Track ENDV — free

Use ENDV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENDV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 At close · Nov 9
Rebalance outlook locked
Going-concern doubt — flagged Dec 29, 2023

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”
View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M
Volume · Nov 9 500K Avg daily vol (3M) 753.37K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2022 Revenue $135.36K up 85.2% 10-K filed Apr 17, 2023 Quarterly report FY2023 Q3 Revenue $1520 down 86.1% 10-Q filed Dec 29, 2023
2024
2023
2022
2021
2020
Showing 1–46 of 46 documents
Key facts CIK 1528172 Visit website